RankingsPricing
  1. JP-listed companies
  2. Mochida Pharmaceutical Co.,Ltd.
  3. Financials
  4. Cash and cash equivalents

Mochida Pharmaceutical Co.,Ltd.【JP:4534】

Market cap
¥135.6B
P/E ratio
24.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 202545,154+35.64%
Mar 31, 202433,290-29.19%
Mar 31, 202347,010-2.90%
Mar 31, 202248,415-11.14%
Mar 31, 202154,487+2.24%
Mar 31, 202053,291+4.43%
Mar 31, 201951,032+11.71%
Mar 31, 201845,683-1.35%
Mar 31, 201746,308+60.15%
Mar 31, 201628,916-6.77%
Mar 31, 201531,016

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)